SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Overview Fund Activity
Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

33 hedge funds and large institutions have $150M invested in Sierra Oncology, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.58%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
11
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$13.6M
2
RSCM
2
Rock Springs Capital Management
Maryland
$17.5M
3
IC
3
Ikarian Capital
Texas
$7.67M
4
OM
4
Opaleye Management
Massachusetts
$2.6M
5
PVI
5
Pura Vida Investments
New York
$1.33M

Top Sellers

1
CC
1
Caxton Corporation
New Jersey
$7.65M
2
6CM
2
683 Capital Management
New York
$0
3
MP
3
Mangrove Partners
Connecticut
$0
4
Northern Trust
4
Northern Trust
Illinois
$319K
5
TRCT
5
Tower Research Capital (TRC)
New York
$7K
Name Holding Trade Value Shares
Change 		Shares
Change %
EWM
26
Elmwood Wealth Management
California
$18K +$18K +1,040 New
SFS
27
Sowell Financial Services
Arkansas
$16K +$16K +871 New
TRCT
28
Tower Research Capital (TRC)
New York
$7K -$27.3K -1,514 -80%
Group One Trading
29
Group One Trading
Illinois
$4K – – –
Wells Fargo
30
Wells Fargo
California
$3K – – –
Osaic Holdings
31
Osaic Holdings
Arizona
$2K +$2K +113 New
RE
32
RBC Europe
United Kingdom
$414 – – –
6CM
33
683 Capital Management
New York
– -$2.25M -140,156 Closed
MP
34
Mangrove Partners
Connecticut
– -$1.75M -108,914 Closed
1
2